Rajendra Achyut Badwe | |
---|---|
Born | Mumbai, Maharashtra, India |
Awards | Padma Shri Lal Bahadur Shastri National Award Reach to Recovery International Medal Joglekar Gold Medal C. V. Menon Gold Medal Life Time Achievement Award Outstanding Service Award |
Rajendra Achyut Badwe, is an Indian medical doctor and surgical oncologist. He was honoured by the Government of India, in 2013, by bestowing on him the Padma Shri, the fourth highest civilian award, for his contributions to the field of medicine. [1] He is the former Director of Tata Memorial Centre, succeeded by Sudeep Gupta [2] [3] [4] [5] [6]
Rajendra Achyut Badwe was born in Mumbai, in the western Indian state of Maharashtra, in 1956. Reported to be a bright student and a winner of the Athalye Medal for Maths, Badwe chose medicine and studied with the Dorab Tata Scholarship, [3] to graduate in medicine (MBBS) in 1978. He was confused about taking engineering or medicine but went with the latter after a coin toss. His post graduation was in general surgery and he secured an MS from Bombay University. [7]
Badwe worked in many institutions of repute before joining Tata Memorial Hospital, Mumbai as the Head of the Department of Surgical Oncology, he worked at the Toronomon Hospital, Tokyo as a Fellow of the International Society for Diseases of the Oesophagus in 1989 and moved to London and worked as the Registrar and honorary consultant at the Guy's Hospital, King's College London School of Medicine and the Royal Marsden Hospital, till 1992. [7]
Rajendra Badwe lives in Mumbai.
Badwe is considered an expert in oncology; his opinions are reportedly considered for devising cancer care strategies, disease management and research protocols worldwide. [7] [3] [4] He is credited with pioneering research in breast cancer treatment, [4] which is his specialty. [8] Some of his researches, such as the one where he subjected 350 women with advanced stages of cancer to chemotherapy are well documented. His studies revealed that the survival rate in cases where surgical procedures are resorted to is almost the same as the cases where only medication was administered and medicines are potent enough to combat breast cancer with the same efficacy as surgery. [6] One of his researches, on the Timing of surgery during the menstrual cycle for operable breast cancer has positive effects on the cancer treatment regimes in the US and the UK. [3] [7] His contributions in the areas such as breast cancer, circulating tumour cells, DNA in solid tumours, clinical research methodology, and epidemiological research in oncology [8] are reported to have enabled a better understanding of the cancer biology and in the development of life saving treatments patterns globally. [7] [4] He is also known for his contributions to contemporary management of oral cavity cancers, leading the first randomized study to demonstrate the benefit of prophylactic treatment of neck lymph nodes in patients without evident nodal disease before surgery. [9]
It is reported that Badwe initiated and implemented the Clinical Research Secretariat for the first time in India. He was also behind the establishment of the Department of Atomic Energy Clinical Trials Centres for multi-centre clinical trials. [7] His mammoth research covering 1000 breast cancer patients in India had a reported effect in reducing breast cancer deaths by 25 per cent. [7]
Badwe has published over 100 research articles in various peer reviewed international and national journals. [7] He serves as a peer reviewer for many journals such as Lancet , British Journal of Cancer , Cancer , International Journal of Surgery , Annals of Oncology , Indian Journal of Surgery and the Indian Journal of Cancer . [7] [8] He has also served as a member of the editorials boards of journals like The Breast Journal and the International Journal of Surgery and Mammology. [8] [7]
Badwe also delivers keynote addresses at various medical seminars. [5]
Rajendra Badwe is the former director of the Tata Memorial Centre and the head of the Department of Surgical Oncology, Tata Memorial Hospital, Mumbai. [7] [5] He is also a member of the International Atomic Energy Agency panel of experts. [8]
The Government of India has utilised his services for setting up cancer care centres in Andhra Pradesh and Punjab. [7] He was a key advisor to the government in the establishment of a National Cancer Centre and six All India Institutes in the fashion of the All India Institute of Medical Sciences. [7] Dr. Badwe is also an advisor to the Government of India, Breast Health Global Initiative [10] and the World Health Organization (WHO) and is the head of the Innovation Council for Cancer Research, a Government of India programme. [7] [3] [4]
Badwe received two awards of repute, in 2013. In January, the Government of India conferred on him the fourth highest civilian award of Padma Shri. Nine months later, in October, the Lal Bahadur Shastri Institute of Management recognised Dr. badwe's services by way of the Lal Bahadur Shastri National Award. [3] [5]
He has also received many other awards such as the Reach to Recovery International Medal of the International Union Against Cancer (UICC),[ citation needed ]Joglekar Gold Medal in 1993, C. V. Menon Gold Medal in 1994 and the Life Time Achievement Award in 2010 and the Outstanding Service Award, both of the Indian Nuclear Society. [7]
The Tata Memorial Hospital (TMH) situated in Parel, Mumbai, is a cancer institute. It is an autonomous institution under the administrative control of Department of Atomic Energy, Government of India. Its current Director is Dr. Sudeep Gupta.
Vasant Ramji Khanolkar, better known as V. R. Khanolkar, was an Indian pathologist. He made major contributions to the epidemiology and understanding of cancer, blood groups, and leprosy. He has been called the "Father of Pathology and Medical Research in India."
Ketayun Ardeshir Dinshaw FRCR was a prominent personality in the field of Indian medicine and played a significant role in the evolution of modern cancer care in India, and the development of effective radiation therapy. In 2001, the President of India conferred on her the Padma Shri. A prominent news channel has described her as: “The ultimate hope and the last possible post to cling onto for the cancer-struck in India”. Over a thirty-year period, Dinshaw revolutionised cancer medicine in India, refining multi-modal treatments as the exception rather than the rule.
Suresh Hariram Advani is an oncologist who pioneered hematopoietic stem cell transplantation in India. Struck by poliomyelitis at the age of 8, he studied at Grant Medical College, Mumbai, where he obtained his MBBS and MD degrees. Following his education, he worked at the Tata Memorial Centre for several years as a medical oncologist. He currently consults at Sushrut Hospital & Research Centre. He gained experience in the field of bone marrow transplantation from the Fred Hutchinson Cancer Research Center in Seattle, Washington.
Dr. Kodaganur S. Gopinath, MS, FAMS, FRCS (Edin) is an Indian surgical oncologist, known for his pioneering work on oncological research. He is a recipient of many awards including Dr. B. C. Roy Award, considered to be the premier medical honour in the country. The President of India recognised his services to the field of oncology, by awarding him the fourth highest civilian award, Padma Shri, in 2010.
Pramod Kumar Julka, is an Indian cancer specialist (oncologist), medical educationist and writer, known for performing the first peripheral blood stem cell transplant following high dose chemotherapy in Metastatic Breast Cancer in India. He was honoured by the Government of India, in 2013, by bestowing on him the Padma Shri, the fourth highest civilian award, for his contributions to the fields of medicine and medical education. The American Society of Clinical Oncology (ASCO) has awarded him by bestowing on him the honorary membership.
Ramakant Krishnaji Deshpande is an Indian surgical oncologist, known as the pioneer of thoracoscopic surgery at the Tata Memorial Hospital. The Government of India honoured him, in 2014, with the award of Padma Shri, the fourth highest civilian award, for his contributions to the fields of medicine.
Dr. Jitendra Kumar Singh is an Indian oncologist, the ex director of Mahavir Cancer Institute & Research Centre and the president of Cancer Care India, the apex body for cancer support organisations in India. He was honoured by the Government of India, in 2012, with the fourth highest Indian civilian award of Padma Shri.
Raghu Ram Pillarisetti is an Indian surgeon, and the Founder and Director of KIMS-Ushalakshmi Center for Breast Diseases at KIMS Hospitals. Pillarisetti is the founder of Ushalakshmi Breast Cancer Foundation, a not-for-profit organisation, and Pink Connexion, a quarterly newsletter about breast healthcare.
Luis Jose De Souza is an Indian surgical oncologist and the founder of Shanti Avedna Ashram, a charitable trust which runs a network of hospices in Mumbai and Goa. He has also contributed to the establishment of Indian Cancer Cell, an educational program co-sponsored by Tata Memorial Centre, Union for International Cancer Control (UICC) and Indian Cancer Society, for creating cancer awareness in schools. The Government of India awarded him the fourth-highest civilian honour of the Padma Shri in 1992.
Narmada Prasad Gupta is an Indian urologist, medical researcher, writer and the chairman of Academics and Research Division Urology at the Medanta, the Medicity, New Delhi. He is credited with over 10,000 urological surgical procedures and the highest number of urology robotics (URobotic) surgeries in India. He is a former head of the department of urology of the All India Institute of Medical Sciences Delhi and a former president of the Urological Society of India. He received the Dr. B. C. Roy Award, the highest Indian award in the medical category, from the Medical Council of India in 2005. The government of India awarded him the fourth highest civilian honour of the Padma Shri, in 2007, for his contributions to Indian medicine.
Darab Jehangir Jussawala (1915–1999) was an Indian medical-cum-surgical oncologist, medical writer and the director of Tata Memorial Centre. He was the co-founder of Indian Cancer Society, along with Naval Tata in 1951, and the founder of the Indian Cancer Rehabilitation Centre in Parel, Mumbai, in 1956, the first such centre in India and the largest in Asia. He served as the director of Lady Ratan Tata Medical and Research Center and as the honorary consultant at two Mumbai hospitals, Breach Candy Hospital and Jaslok Hospital. An elected fellow of the Royal Society of Medicine, National Academy of Medical Sciences, Indian Academy of Sciences, Indian National Science Academy and the American College of Surgeons, he was a recipient of the Dhanwantari Award as well as several Oration Awards. The Government of India awarded him the third highest civilian honour of the Padma Bhushan, in 1975, for his contributions to Medicine.
Prafulla B. Ragubhai Desai is an Indian surgical oncologist and a former chairman of the Research Advisory Committee on Oncology of the Indian Council of Medical Research. He is credited with the first bone marrow transplantation in India, which he performed with his team in 1983. He is a former director and superintendent at Tata Memorial Centre, Mumbai (1973–1995) and continues his association with the institution as their professor emeritus. He is one of the founders of the Rural Cancer Centre established by Tata Memorial Centre at Barshi, Mumbai and serves Breach Candy Hospital as a surgical oncologist and the Indo-Global Summit on Head and Neck Oncology (IGSHNO) as a member of their national faculty.
Sandip Basu is an Indian physician of Nuclear Medicine and the Head, Nuclear Medicine Academic Program at the Radiation Medicine Centre. He is also the Dean-Academic (Health-Sciences), BARC at Homi Bhabha National Institute and is known for his services and research in Nuclear Medicine, particularly on Positron emission tomography diagnostics and Targeted Radionuclide Therapy in Cancer. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Nuclear Medicine in 2012.
Ravi Kannan R is an Indian surgical oncologist, based in Assam. He is the director of Cachar Cancer Hospital and Research Centre (CCHRC), Silchar, a nonprofit hospital, that provides free cancer treatment. He is the former Head of Department of surgical oncology at Adyar Cancer Institute in Chennai. He is a recipient of Padma Shri, one of India's highest civilian honours, and the Ramon Magsaysay Award, the highest award in Asia.
Jayant S. Vaidya is a British-Indian surgeon-oncologist and clinical academic who, together with Michael Baum and Jeffrey Tobias, developed the technique called targeted intra-operative radiotherapy (TARGIT). He is a professor of surgery and oncology at the University College London, London and the author of two books on breast cancer, one on tobacco eradication, and over 200 academic articles.
Somashekhar SP is an Indian robotic surgeon, author and chairman of medical advisory board at Aster DM Healthcare - GCC & India. He is also the global director of Aster International Institute of Oncology in GCC & India. He is the president of the Association of Breast Surgeons of India, editor in chief of the IJGO Springer Indian Journal of Gynec Oncology and council member of The Association of Surgeons of India. He is also the editor of Annals of Breast Diseases.
Indraneel Mittra FRCS (England), FASc, FNA is an Indian cancer surgeon, basic research scientist, and public health researcher. He is the Dr. Ernest Borges Chair in Translational Research and Professor Emeritus in the Department of Surgical Oncology, Tata Memorial Centre (TMC) in Mumbai. He established the first dedicated multi-disciplinary Breast Unit in India – a model which has since been adopted by most centers in the country. He pioneered the discipline of clinical research in cancer in India and pursued the cause of improving cancer care in the developing world. In this context, and with an RO1 grant from the National Institutes of Health (NIH) of the United States, Mittra spearheaded one of the largest randomized trials of screening for early detection of breast and cervical cancer using low-cost technology approaches involving 150,000 women in the suburbs of Mumbai. He is the first Indian recipient of such a competitive grant from the NIH. In the field of laboratory research, he is credited with having discovered the wide-ranging biological activities of cell-free chromatin particles (cfChPs), which have critical implications for human health and disease, and how deactivating cfChPs can have many therapeutic effects. Prof. Mittra’s current research interests revolve around studying cfChPs in the context of evolution.
Ernest Joachim Joseph Borges was an Indian oncologist and cancer surgeon known for his contributions to the field of oncology in India. He pioneered cancer treatment in India during a period when radiation therapy and chemotherapy were in their early stages of development, while surgery remained the predominant option for cancer patients. He served as the Director and Superintendent of Tata Memorial Hospital from 1967 to 1969. In 1966, he was honored with the Padma Shri, the third highest civilian award, by the Government of India.
Sudeep Gupta is an Indian medical oncologist. He is the Director of Tata Memorial Hospital, Mumbai, the apex centre for cancer treatment, research and education in India.